Meldungen sortieren nach Relevanz Meldungsdatum
|
Roche Diagnostics supports European Union's DETECTIVE Project to reduce Animal Testing
, Biotechnik, Roche Diagnostics GmbH
The xCELLigence RTCA System of Roche (SIX: RO, ROG; OTCQX: RHHBY) is being used in the European Union's DETECTIVE ("Detection of endpoints and biomarkers for repeated...
|
|
Roche Diagnostics unterstützt das DETECTIVE-Projekt der Europäischen Union zur Reduzierung von Tierversuchen
, Biotechnik, Roche Diagnostics GmbH
Das xCELLigence RTCA-System von Roche (SIX: RO, ROG; OTCQX: RHHBY) wird im Forschungsprojekt DETECTIVE ("Detection of endpoints and biomarkers for repeated dose...
|
|
Roche and Fluidigm Corporation Enter Worldwide Co-Promotion Agreement for 454 Sequencing Systems and Access Array(TM) Platform
, Biotechnik, Roche Diagnostics GmbH
454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the companies' complementary...
|
febit Receives European Union (EU) Patent for Synthesis of Minimal Genomes
, FirmenIntern, febit holding gmbh
febit announced today the receipt of an EU patent, #EP 1 728 860B1, for its technology to synthesize minimal genomes. The new patent protects febit's technology...
|
|
The Scientist Magazine Recognizes febit's HybSelectTM Among the Winners of "Top 10 Innovations of 2009"
, Biotechnik, febit holding gmbh
febit's HybSelect has been recognized as one of the winners of the "Top 10 Innovations of 2009" by The Scientist magazine. The company's automated sequence capture...
|
|
First Biomarker Experts Workshop in Heidelberg Successful
, Biotechnik, febit holding gmbh
A panel of more than 30 experts in molecular diagnostics participated in the first workshop of the Biomarker Discovery Center (BDC) held on September 29, 2009 in...
|
|
Life Technologies and febit Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies
, Biotechnik, febit holding gmbh
febit's HybSelectTM technology for sequence capture combined with Applied Biosystems' SOLiD(TM) System enable automated, high sample throughput next generation sequencing. febit...
|
febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment
, Hardware, febit holding gmbh
febit holding gmbh announced today the launch of the first biochip on the market covering the newly published whole mouse genome. The biochip from febit enables...
|
|
febit Receives European Patent for Gene Extraction Procedure
, Biotechnik, febit holding gmbh
febit holding gmbh announced today, that the company has been granted the first European patent (EP1436609) for a microarray-based nucleic acid extraction procedure....
|
Paul Keim Appointed to febit's Scientific Advisory Board
, FirmenIntern, febit holding gmbh
Paul Keim brings deep knowledge in the field of medical microbiology, biodefense and pathogens to febit, the leader in microfluidic microarray DNA analysis technologies febit...
|
|
Webinar: The Power to Detect: HybSelect for Targeted Sequence Capture
, FirmenIntern, febit holding gmbh
The proliferation of Next-Gen Sequencing (NGS) platforms has increased DNA sequencing throughput by orders of magnitude, however, it still takes months and several...
|
|
febit to Receive Funding from a Federal Grant Awarded in the German Excellence Cluster Contest
, Biotechnik, febit holding gmbh
As early as mid-February, febit will start setting up the Biomarker Discovery Center Heidelberg, one of the projects recently awarded funding from the Excellence...
|
febit Appoints Jack Leonard, Ph.D., Vice President of Technology Commercialization
, FirmenIntern, febit holding gmbh
febit holding GmbH, a developer of the flexible and automated biochip-based DNA-analysis platform Geniom®, today announced the appointment of Jack Leonard, Ph.D.,...
|
|
febit Receives US Patent for Microfluidic Extraction Method
, Biotechnik, febit holding gmbh
febit today announced the receipt of US patent #7320862 on its microfluidic microarray-based method for extraction of DNA and RNA. This method forms the basis...
|
NANOIDENT Technologies AG kooperiert mit Technologieführern für die Europäische Verteidigungsagentur bei der Detektion aerogener Krankheitserreger
, Kooperationen / Fusionen, NANOIDENT Technologies AG
NANOIDENT Technologies AG, führend in der Entwicklung und Fertigung optoelektronischer Sensoren auf der Basis gedruckter Halbleiter, gab heute bekannt, dass das...
Ähnliche Keywords
Firmen
Kategorien
Alle Kategorien
